A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is a Phase II clinical study to evaluate the efficacy and safety of intravesical T3011 injection in participants with BCG-unresponsive high-risk NMIBC or BCG-exposed, chemotherapy-unresponsive intermediate/high-risk NMIBC.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Potwierdzony rozpoznaniem raka pęcherza moczowego (nieinwazyjny, w wczesnym stadium)
- •Chęć uczestnictwa w badaniu i zgodę na przeprowadzanie cystoskopii (badania pęcherza), badania moczu i biopsji
- •Wyleczenie się z powikłań poprzedniego leczenia (chemioterapia, radioterapia)
- •Ogólny stan zdrowia pozwalający na uczestnictwo w badaniu
- •Oczekiwana przeżywalność co najmniej 24 tygodnie
- •Prawidłowe wyniki badań laboratoryjnych (krew, nerki, wątroba, krzepnięcie)
- •Dla kobiet: ujemny test ciążowy i stosowanie antykoncepcji przez 6 miesięcy po leczeniu
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 18, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (9)
East Valley Urology Center
Queen Creek, United States
Tower Urology
Los Angeles, United States
Advent Health Medical Group Urology
Orlando, United States
Florida Urology Partners, LLP
Tampa, United States
Rutgers Cancer Institute
New Brunswick, United States
University of Cincinnati Medical Center
Cincinnati, United States
Helios Clinical Research
Middleburg Heights, United States
Allegheny Health Network
Pittsburgh, United States
Carolina Urologic Research Center
Myrtle Beach, United States
Trial contact
Jasmine Yang
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/19/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.